Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by 4Justiceon Sep 03, 2020 1:25pm
268 Views
Post# 31504686

RE:RE:RE:RE:RE:+++ The 2 people they hired +++

RE:RE:RE:RE:RE:+++ The 2 people they hired +++It's obvious that the new board members are there to recover Thomvest money. They will act quickly because Liminal has less then $10 millions in cash and the credit margin of $26 millions is again Thomvest money. They don't wait a year and spend more for the Ryplazim and FDA green light.
The next step will be the dismissal of Galbraith and Sartore. They delivered nothing with a blockbuster company. 
<< Previous
Bullboard Posts
Next >>